Molecular-biological studies about the fate of micronuclei: underlying mechanisms and toxicological relevance
关于微核命运的分子生物学研究:潜在机制和毒理学相关性
基本信息
- 批准号:329439085
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:德国
- 项目类别:Research Grants
- 财政年份:2016
- 资助国家:德国
- 起止时间:2015-12-31 至 2022-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Different types of mutations play a major role in carcinogenesis, e. g. chromosomal mutations, which are characterized by modifications of the chromosome structure. One form of manifested chromosomal mutations are so-called micronuclei that are formed from chromosomal fragments or missegregated chromosomes. The formation of micronuclei has been investigated thoroughly and the underlying mechanisms are well understood. However, it is less clear whether micronuclei persist within the cell or whether there are any specific mechanisms of elimination. In principle, there could be four possibilities: persistence in the cell, degradation, extrusion from the cell or reintegration into the main nucleus. In the previous project, the fate of micronuclei and the relevance for the whole cell was addressed systematically for the first time. In the project now proposed, the underlying mechanisms shall be identified and characterized.In the previous project, a system for live cell microscopy was established. In preliminary tests, suitable experimental conditions were identified, such as micronucleus-inducing substances, concentrations, treatment times, imaging conditions, and evaluation criteria. Cells were followed for 96 hours and evaluated. Overall, most cells persisted without any change. Some micronuclei were reincorporated into the main nucleus. Degradation and extrusion were rare events. Differences between the substances were not observed.In the project proposed here, the underlying mechanisms shall be investigated. To this end, the question whether the content of a micronucleus is responsible for a specific fate will be addressed. In this context, it is of particular interest whether micronuclei contain whole chromosomes or fragments. For the investigation of the degradation of micronuclei, putative dissociation pathways will be analysed, including autophagy and lysosomal degradation. For the analysis of reincorporation and extrusion from the cell, the involvement of structural proteins of the cytoskeleton will be investigated. This will help elucidating the role of the cytoskeleton for the localisation of micronuclei and for their transport to the main nucleus (indicating reincorporation) or to the cell membrane (indicating extrusion).These experiments will help understanding the mechanistic backgrounds of the different fates of micronuclei.
不同类型的突变在癌发生中起主要作用,例如:G.染色体突变,其特征在于染色体结构的修饰。染色体突变的一种表现形式是所谓的微核,它是由染色体片段或错误分离的染色体形成的。已对微核的形成进行了全面研究,并充分了解了其潜在机制。然而,目前尚不清楚微核是否在细胞内持续存在或是否有任何特定的消除机制。原则上,可能有四种可能性:在细胞中持续存在,降解,从细胞中挤出或重新融入主核。在上一个项目中,首次系统地讨论了微核的命运及其与整个细胞的相关性。在现在提出的项目中,将确定和表征潜在的机制。在前一个项目中,建立了一个活细胞显微镜系统。在初步试验中,确定了合适的实验条件,如微核诱导物质、浓度、处理时间、成像条件和评价标准。跟踪细胞96小时并进行评价。总的来说,大多数细胞没有任何变化。一些微核重新并入主核。降解和挤出是罕见事件。在这里提议的项目中,将调查潜在的机制。为此,将讨论微核的含量是否对特定命运负责的问题。在这种情况下,它是特别感兴趣的微核是否包含整个染色体或片段。为了研究微核降解,将分析推定的解离途径,包括自噬和溶酶体降解。为了分析再掺入和从细胞中挤出,将研究细胞骨架结构蛋白的参与。这将有助于阐明细胞骨架在微核定位及其向主核(表明再结合)或细胞膜(表明挤出)运输中的作用,这些实验将有助于理解微核不同命运的机制背景。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Professor Dr. Henning Hintzsche其他文献
Professor Dr. Henning Hintzsche的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
生物钟核受体Rev-erbα在缺血性卒中神经元能量代谢中的改善作用及机制研究
- 批准号:82371332
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
过表达CX45联合HCN4基因转染对起搏细胞自律性的影响
- 批准号:81170174
- 批准年份:2011
- 资助金额:50.0 万元
- 项目类别:面上项目
美洲大蠊药材养殖及加工过程中化学成分动态变化与生物活性的相关性研究
- 批准号:81060329
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
慢病毒转染嵌合体HCN1+4拼接基因构建生物起搏细胞
- 批准号:81070139
- 批准年份:2010
- 资助金额:33.0 万元
- 项目类别:面上项目
岭南瑶区几种瑶族抗肝炎植物药的化学成分及生物活性研究
- 批准号:20772047
- 批准年份:2007
- 资助金额:28.0 万元
- 项目类别:面上项目
TB方法在有机和生物大分子体系计算研究中的应用
- 批准号:20773047
- 批准年份:2007
- 资助金额:26.0 万元
- 项目类别:面上项目
天然生物材料的多尺度力学与仿生研究
- 批准号:10732050
- 批准年份:2007
- 资助金额:200.0 万元
- 项目类别:重点项目
相似海外基金
Molecular predictors of cardiovascular events and resilience in chronic coronary artery disease
心血管事件的分子预测因素和慢性冠状动脉疾病的恢复力
- 批准号:
10736587 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Leveraging Molecular Technologies to Improve Diagnosis and Management of Pediatric Acute Respiratory Illness in Resource-Constrained Settings
利用分子技术改善资源有限环境中儿科急性呼吸系统疾病的诊断和管理
- 批准号:
10739603 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Molecular Biomarkers in pathogenesis of Lymphangioleiomyomatosis (LAM)
淋巴管平滑肌瘤病 (LAM) 发病机制中的分子生物标志物
- 批准号:
10745193 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Clinical, molecular, and immune characterization of naturally occurring osteosarcoma in dogs
犬自然发生的骨肉瘤的临床、分子和免疫特征
- 批准号:
10717426 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Validation of an aqueous humor liquid biopsy for molecular prognostication and monitoring of children with retinoblastoma.
房水液体活检对视网膜母细胞瘤儿童分子预测和监测的验证。
- 批准号:
10718932 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Non-invasive molecular imaging tool for rapid, longitudinal assessment of localized metabolic disruptions in animal research and care
非侵入性分子成像工具,用于快速纵向评估动物研究和护理中的局部代谢紊乱
- 批准号:
10602045 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Discovering Centrally Linked Peripheral Molecular Signatures of Alzheimer's Disease
发现阿尔茨海默病的中心连锁外周分子特征
- 批准号:
10555727 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Validation of novel imaging and molecular tests for early detection of pancreatic cancer through risk-stratified community engagement programs
通过风险分层社区参与计划验证用于早期检测胰腺癌的新型成像和分子测试
- 批准号:
10640704 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Core B: Translational, Cellular and Molecular Analysis
核心 B:转化、细胞和分子分析
- 批准号:
10715766 - 财政年份:2023
- 资助金额:
-- - 项目类别: